Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

First Use of Phage Therapy in Canada for the Treatment of a Life-Threatening, Multidrug-Resistant Staphylococcus epidermidis Periprosthetic Joint Infection

14 Aug 2025

Abstract excerpt

We describe the first use of phage therapy in Canada for the treatment of a life-threatening periprosthetic joint infection (PJI), with successful outcome. PJI is a devastating complication of joint replacement surgery, with high morbidity and mortality. Our patient presented with early sepsis from a chronic recalcitrant multidrug-resistant (MDR) Staphylococcus epidermidis hip PJI which had repeatedly failed...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibiotic Resistance in Bacteria
Share to Bacteriophages and microbial interactions
Share to Orthopedic Infections and Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 40872831
DOI: 10.3390/v17081118

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

First Use of Phage Therapy in Canada for the Treatment of a Life-Threatening, Multidrug-Resistant Staphylococcus epidermidis Periprosthetic Joint InfectionPMID 40872831Read ↗

Bacteriophage therapy created the necessary conditions for successful antibiotic suppression in a periprosthetic hip joint infection: a Case ReportSemantic proximity Read ↗

Bacteriophage Application for Difficult-To-Treat Musculoskeletal Infections: Development of a Standardized Multidisciplinary Treatment ProtocolSemantic proximity Read ↗

Osteoarticular prosthetic infection: how many patients are eligible for phage therapy? A French single-centre retrospective studySemantic proximity Read ↗

Past and Future of Phage Therapy and Phage-Derived Proteins in Patients with Bone and Joint InfectionSemantic proximity Read ↗

Antibiotic Prophylaxis in Total Joint ArthroplastySemantic proximity Read ↗

Assessment of Bacteriophage Pharmacokinetic Parameters After Intra-Articular Delivery in a Rat Prosthetic Joint Infection ModelSemantic proximity Read ↗

Bacteriophage therapy for periprosthetic joint infections: Current limitations and research needed to advance this therapeuticSemantic proximity Read ↗

What’s New in Musculoskeletal Infection: Update on BiofilmsSemantic proximity Read ↗

Phage Activity against Planktonic and Biofilm Staphylococcus aureus Periprosthetic Joint Infection IsolatesSemantic proximity Read ↗

Analysis of phage therapy failure in a patient with a<i>Pseudomonas aeruginosa</i>prosthetic vascular graft infectionSemantic proximity Read ↗

Therapeutic monitoring of the host-bacterium-phage interaction in a childSemantic proximity Read ↗

Successful phage-antibiotic therapy of P. aeruginosa implant-associated infection in a Siamese catSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.